>中東およびアフリカの下剤市場、タイプ別（浸透性下剤、刺激性下剤、膨張性下剤、潤滑性および皮膚軟化性下剤）、フレーバー（フレーバー付きおよびフレーバーなし）、ソース（天然、合成、その他）、適応症（慢性便秘、便秘を伴う過敏性腸症候群、オピオイド誘発性便秘、急性便秘、その他）、購入方法（処方箋および市販薬）、剤形（錠剤、カプセル、粉末、液体およびゲル、坐薬、その他）、投与経路（経口および直腸）、人口タイプ（子供および成人）、販売チャネル（病院、高齢者ケアセンター、在宅医療、薬局、食料品店/健康および美容店、その他）、流通チャネル（直接販売、卸売業者、その他）、国（南アフリカ、サウジアラビア、アラブ首長国連邦、エジプト、クウェート、イスラエル、その他の中東およびアフリカ諸国の産業動向と 2028 年までの予測。
市場分析と洞察：中東およびアフリカの下剤市場
中東およびアフリカの下剤市場は、2021年から2028年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に4.9％のCAGRで成長し、2028年までに3億9,624万米ドルに達すると分析しています。下剤製品に関連する高い安全性と、天然、合成、生分解性材料からの下剤の生産への重点の高まりが、予測期間における市場の需要を推進する主な原動力となっています。
下剤は、排便を促進/刺激したり、便を緩めたりする薬剤です。腸の通過を早め、消化管の動きを速めて排便を刺激します。便秘の治療に使用されます。便秘とは、排便が困難で、排便回数が少なく、時には痛みを伴う症状を特徴とする疾患です。下剤は市販薬 (OTC)として入手できます。下剤には、浸透圧性下剤、刺激性下剤、膨張性下剤、潤滑剤、および皮膚軟化剤の 4 つの主な種類があります。
下剤には、安全で効果的な製品に対する需要の高まりがメーカーによる新製品の市場投入に影響を与え、需要が高まるとともに、研究開発への投資の増加が市場の成長につながるという特徴があります。現在、さまざまな研究調査が行われており、メーカーが新しい革新的な製品を開発するための競争上の優位性が生まれ、下剤市場にさまざまな機会がもたらされると期待されています。ただし、代替製品の入手可能性とオピオイド誘発性便秘に対する下剤の効能の低さは、予測期間中の市場の成長を抑制する要因になると予想されます。
下剤市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から見た機会の分析が提供されます。分析と市場シナリオを理解するには、アナリスト概要についてお問い合わせください。当社のチームが、希望する目標を達成するための収益影響ソリューションの作成をお手伝いします。
中東およびアフリカの下剤市場の範囲と市場規模
中東およびアフリカの下剤市場は、種類、風味、供給元、適応症、購入方法、剤形、投与経路、人口タイプ、販売チャネル、流通チャネルに基づいて、10 の重要なセグメントに分類されています。セグメント間の成長は、成長のニッチな分野と市場にアプローチするための戦略を分析し、コア アプリケーション領域とターゲット市場の違いを決定するのに役立ちます。
- タイプに基づいて、中東およびアフリカの下剤市場は、浸透性下剤、膨張性下剤、刺激性下剤、潤滑性および皮膚軟化性下剤に分類されます。2021年には、刺激性下剤セグメントが市場を支配しています。これは、これらの下剤の機能が腸の検査/手術の前に腸をきれいにするために使用されるためです。
- 中東およびアフリカの下剤市場は、フレーバーに基づいてフレーバー付きとフレーバーなしに分類されます。2021年には、市場での受け入れと消費者の間での人気により、フレーバー付きセグメントが市場を支配しています。
- 中東およびアフリカの下剤市場は、供給源に基づいて、天然、合成、その他に分類されます。2021 年には、市販薬として合成下剤が利用しやすくなったため、合成セグメントが市場を支配しています。
- 適応症に基づいて、中東およびアフリカの下剤市場は、慢性便秘、便秘を伴う過敏性腸症候群、オピオイド誘発性便秘、急性便秘などに分類されます。2021年には、便秘用のOTC薬が容易に入手できるため、慢性便秘セグメントが市場を支配します。
- 購入方法に基づいて、中東およびアフリカの下剤市場は処方薬と市販薬に分類されます。2021年には、コストが低く、患者のニーズに応じて薬をカスタマイズできるため、市販薬セグメントが市場を支配しています。
- 剤形に基づいて、中東およびアフリカの下剤市場は、錠剤、カプセル、粉末、液体およびゲル、坐薬、その他に分類されます。2021年には、錠剤セグメントが最も経済的な薬物投与方法であるため、市場を支配しています。
- 投与経路に基づいて、中東およびアフリカの下剤市場は経口と直腸に分割されます。2021年には、経口セグメントが最も安全で、最も便利で、経済的な薬物投与方法であるため、市場を支配しています。
- 人口タイプに基づいて、中東およびアフリカの下剤市場は子供と大人に分割されています。2021年には、旅行や食事、就寝時間の差など、日常生活の変化により、成人セグメントが中東およびアフリカの下剤市場を支配すると予想されます。
- 販売チャネルに基づいて、中東およびアフリカの下剤市場は、病院、高齢者ケアセンター、在宅医療、薬局、食料品店/健康および美容店、その他に分類されます。病院は組織化された医療および専門スタッフを擁する医療機関であるため、2021年には病院セグメントが中東およびアフリカの下剤市場を支配すると予想されます。病院は患者に医療、看護、およびその他の健康関連サービスを提供します。
- 流通チャネルに基づいて、中東およびアフリカの下剤市場は、直接販売、卸売、その他に分類されます。2021年には、直接販売セグメントが中東およびアフリカの下剤市場を支配すると予想されます。これは、販売者と直接連絡を取り、製品を顧客に直接販売できるためです。
下剤市場の国別分析
下剤市場を分析し、種類、風味、供給元、適応症、購入方法、剤形、投与経路、対象者タイプ、販売チャネル、流通チャネルに基づいて市場規模の情報を提供します。
下剤市場レポートで取り上げられている国は、サウジアラビア、南アフリカ、UAE、イスラエル、クウェート、エジプト、およびその他の中東およびアフリカ諸国です。
中東・アフリカ地域では、高齢者人口の増加と飲料の消費量の増加により便秘の問題が生じているため、南アフリカとクウェートが2021年から2028年の予測期間に最も高い成長率で成長すると予想されています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、中東およびアフリカのブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響を考慮しながら、国別データの予測分析を提供します。
高齢者人口の増加により中東・アフリカ地域で下剤市場の成長が促進される
下剤市場では、下剤の売上、下剤技術の進歩の影響、下剤市場へのサポートに関する規制シナリオの変化など、下剤製品産業の各国での成長に関する詳細な市場分析も提供しています。データは、2010年から2019年までの履歴期間について入手できます。
競争環境と下剤市場シェア分析
下剤市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、下剤市場に関連する会社の焦点にのみ関連しています。
中東およびアフリカの下剤市場で取引のある主要企業には、Boehringer Ingelheim International GmbH、GlaxoSmithKline plc.、Bayer AG、Fresenius Kabi Austria GmbH、Procter & Gamble、Sun Pharmaceutical Industries Ltd.、Sanofi Aventis US LLC (Sanofi の子会社)、Mallinckrodt、Abbott、Hikma Pharmaceuticals PLC、Dr Reddy's Laboratories Ltd、Cipla Inc.、Albert David Ltd、Aspen Pharmacare Australia Pty Ltd、RECORDATI SpA などがあります。DBMR のアナリストは、競争力を理解し、各競合他社の競合分析を個別に提供します。
世界中の企業によって多くの製品の発売や契約も開始されており、下剤市場の拡大も加速しています。
例えば、
- 2018年1月、バイエルAGは、人気の便秘薬ミララックスを発売しました。ミララックスにはFDAから猶予が与えられました。FDAは、この薬はさらに6か月間訴訟されると述べています。バイエルAGは、行動障害などの副作用を引き起こしたため、下剤の流通を中止しました。その結果、純利益の損失と市場のマイナス成長につながりました。
- 2021年10月、アボットはインドでデュファラック下剤を発売しました。ストロベリー味のデュファラックベアは下剤兼食品サプリメントで、FSSAI規制に適合しています。信頼できるプレバイオティクスの利点を提供し、消化器系における善玉菌の増殖を促します。この製品の発売は、子どもたちの健康改善に向けた重要な一歩となるでしょう。これにより、純売上高が増加し、製品範囲が拡大するでしょう。
市場プレーヤーによるコラボレーション、製品の発売、事業拡大、賞や表彰、合弁事業、その他の戦略により、下剤市場における企業市場が強化され、組織にとっても下剤の提供を改善するメリットがもたらされます。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA LAXATIVE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MIDDLE EAST AND AFRICA LAXATIVE MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET INDICATION COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTERS FIVE FORCES MODEL
4.2 PESTEL ANALYSIS
5 EPIDEMIOLOGY
6 MIDDLE EAST AND AFRICA LAXATIVE MARKET: REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASED PREVALENCE OF CONSTIPATION
7.1.2 RISE IN CLINICAL TRIALS
7.1.3 ACCLIMATIZATION OF SEDENTARY LIFESTYLE
7.1.4 RISE IN GERIATRIC POPULATION
7.1.5 RISE IN PRODUCT APPROVALS
7.2 RESTRAINTS
7.2.1 LESS EFFICACY OF LAXATIVES FOR OPIOID-INDUCED CONSTIPATION
7.2.2 AVAILABILITY OF ALTERNATIVES
7.2.3 LAXATIVE ABUSE
7.2.4 SIDE EFFECTS RELATED TO THE USE OF LAXATIVES
7.3 OPPORTUNITIES
7.3.1 RISE OF OTC LAXATIVE MEDICATIONS
7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.3.3 INCREASED USE OF BULK-LAXATIVES
7.4 CHALLENGES
7.4.1 RISE OF PRODUCT RECALL
7.4.2 PATIENT COMPLIANCE REGARDING THE USE OF LAXATIVES
8 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA LAXATIVE MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
8.5 CONCLUSION
9 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY TYPE
9.1 OVERVIEW
9.2 OSMOTIC LAXATIVES
9.2.1 OSMOTIC LAXATIVES WITHOUT ELECTROLYTES
9.2.1.1 LACTULOSE
9.2.1.2 MAGNESIUM HYDROXIDE SOLUTION
9.2.1.3 EPSOM SALTS
9.2.1.4 OTHERS
9.2.2 OSMOTIC LAXATIVES WITH ELECTROLYTES
9.2.2.1 GOLYTELY
9.2.2.2 COLYTE
9.2.2.3 OTHERS
9.3 STIMULANT LAXATIVES
9.3.1 BISACODYL
9.3.2 CASTOR OIL
9.3.3 SENNA
9.3.4 PHENOLPHTALEIN
9.3.5 OTHERS
9.4 BULK LAXATIVES
9.4.1 PSYLLIUM
9.4.2 METHYL CELLULOSE
9.4.3 POLYCARBOPHIL
9.4.4 OTHERS
9.5 LUBRICANT AND EMOLLIENT LAXATIVES
9.5.1 MINERAL OIL
9.5.2 GLYCERIN SUPPOSITORIES
9.5.3 OTHERS
10 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY FLAVORS
10.1 OVERVIEW
10.2 WITH FLAVOR
10.2.1 FRUIT FLAVOR
10.2.2 HERBAL FLAVOR
10.2.3 OTHERS
10.3 WITHOUT FLAVOR
11 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY SOURCE
11.1 OVERVIEW
11.2 SYNTHETIC
11.2.1 BISACODYL
11.2.2 PICOSULPHATE
11.2.3 PHENOLPHTHALEIN
11.2.4 OXYPHENISATIN
11.3 NATURAL
11.3.1 PSYLLIUM
11.3.2 SENNA
11.3.3 RHUBARB
11.3.4 SLIPPERY ELM
12 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY INDICATION
12.1 OVERVIEW
12.2 CHRONIC CONSTIPATION
12.3 IRRITABLE BOWEL SYNDROME WITH CONSTIPATION
12.4 OPIOID-INDUCED CONSTIPATION
12.5 ACUTE CONSTIPATION
12.6 OTHERS
13 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE
13.1 OVERVIEW
13.2 OVER THE COUNTER
13.3 PRESCRIPTION
14 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY DOSAGE FORM
14.1 OVERVIEW
14.2 TABLETS
14.3 CAPSULES
14.4 POWDER
14.5 LIQUID & GELS
14.6 SUPPOSITORIES
14.7 OTHERS
15 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION
15.1 OVERVIEW
15.2 ORAL
15.3 RECTAL
16 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY POPULATION TYPE
16.1 OVERVIEW
16.2 ADULTS
16.3 CHILDREN
17 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY SALES CHANNEL
17.1 OVERVIEW
17.2 HOSPITALS
17.3 PHARMACY STORES
17.4 ELDERLY CARE CENTERS
17.5 HOME HEALTHCARE
17.6 GROCERY/HEALTH AND BEAUTY STORES
17.7 OTHERS
18 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL
18.1 OVERVIEW
18.2 DIRECT SALES
18.3 WHOLE SALERS
18.4 OTHERS
19 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY REGION
19.1 MIDDLE EAST & AFRICA
19.1.1 SAUDI ARABIA
19.1.2 SOUTH AFRICA
19.1.3 U.A.E.
19.1.4 ISRAEL
19.1.5 KUWAIT
19.1.6 EGYPT
19.1.7 REST OF MIDDLE EAST & AFRICA
20 MIDDLE EAST AND AFRICA LAXATIVE MARKET: COMPANY LANDSCAPE
20.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
21 SWOT ANALYSIS
22 COMPANY PROFILE
22.1 BAYER AG
22.1.1 COMPANY SNAPSHOT
22.1.2 REVENUE ANALYSIS
22.1.3 COMPANY SHARE ANALYSIS
22.1.4 PRODUCT PORTFOLIO
22.1.5 RECENT DEVELOPMENT
22.2 PROCTER & GAMBLE
22.2.1 COMPANY SNAPSHOT
22.2.2 REVENUE ANALYSIS
22.2.3 COMPANY SHARE ANALYSIS
22.2.4 PRODUCT PORTFOLIO
22.2.5 RECENT DEVELOPMENTS
22.3 FRESENIUS KABI AUSTRIA GMBH (A SUBSIDIARY OF FRESENIUS KABI AG)
22.3.1 COMPANY SNAPSHOT
22.3.2 REVENUE ANALYSIS
22.3.3 COMPANY SHARE ANALYSIS
22.3.4 PRODUCT PORTFOLIO
22.3.5 RECENT DEVELOPMENT
22.4 SANOFI-AVENTIS U.S. LLC (A SUBSIDIARY OF SANOFI)
22.4.1 COMPANY SNAPSHOT
22.4.2 REVENUE ANALYSIS
22.4.3 COMPANY SHARE ANALYSIS
22.4.4 PRODUCT PORTFOLIO
22.4.5 RECENT DEVELOPMENTS
22.5 ABBOTT
22.5.1 COMPANY SNAPSHOT
22.5.2 REVENUE ANALYSIS
22.5.3 PRODUCT PORTFOLIO
22.5.4 RECENT DEVELOPMENT
22.6 ALBERT DAVID LTD.
22.6.1 COMPANY SNAPSHOT
22.6.2 REVENUE ANALYSIS
22.6.3 PRODUCT PORTFOLIO
22.6.4 RECENT DEVELOPMENT
22.7 ASPEN PHARMACARE AUSTRALIA PTY LTD. (A SUBSIDIARY OF ASPEN HOLDINGS)
22.7.1 COMPANY SNAPSHOT
22.7.2 REVENUE ANALYSIS
22.7.3 PRODUCT PORTFOLIO
22.7.4 RECENT DEVELOPMENT
22.8 AVRIO HEALTH L.P.
22.8.1 COMPANY SNAPSHOT
22.8.2 PRODUCT PORTFOLIO
22.8.3 RECENT DEVELOPMENT
22.9 BIOCHEMIX HEALTHCARE PVT. LTD.
22.9.1 COMPANY SNAPSHOT
22.9.2 PRODUCT PORTFOLIO
22.9.3 RECENT DEVELOPMENT
22.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
22.10.1 COMPANY SNAPSHOT
22.10.2 REVENUE ANALYSIS
22.10.3 PRODUCT PORTFOLIO
22.10.4 RECENT DEVELOPMENT
22.11 CIPLA INC.
22.11.1 COMPANY SNAPSHOT
22.11.2 REVENUE ANALYSIS
22.11.3 PRODUCT PORTFOLIO
22.11.4 RECENT DEVELOPMENTS
22.12 DR. REDDY’S LABORATORIES LTD.
22.12.1 COMPANY SNAPSHOT
22.12.2 REVENUE ANALYSIS
22.12.3 PRODUCT PORTFOLIO
22.12.4 RECENT DEVELOPMENTS
22.13 GLAXOSMITHKLINE PLC
22.13.1 COMPANY SNAPSHOT
22.13.2 REVENUE ANALYSIS
22.13.3 PRODUCT PORTFOLIO
22.13.4 RECENT DEVELOPMENT
22.14 HERMES PHARMA
22.14.1 COMPANY SNAPSHOT
22.14.2 PRODUCT PORTFOLIO
22.14.3 RECENT DEVELOPMENTS
22.15 HIKMA PHARMACEUTICALS PLC
22.15.1 COMPANY SNAPSHOT
22.15.2 REVENUE ANALYSIS
22.15.3 PRODUCT PORTFOLIO
22.15.4 RECENT DEVELOPMENT
22.16 LNK INTERNATIONAL, INC.
22.16.1 COMPANY SNAPSHOT
22.16.2 PRODUCT PORTFOLIO
22.16.3 RECENT DEVELOPMENT
22.17 MALLINCKRODT
22.17.1 COMPANY SNAPSHOT
22.17.2 REVENUE ANALYSIS
22.17.3 PRODUCT PORTFOLIO
22.17.4 RECENT DEVELOPMENTS
22.18 PRESTIGE CONSUMER HEALTHCARE INC.
22.18.1 COMPANY SNAPSHOT
22.18.2 REVENUE ANALYSIS
22.18.3 PRODUCT PORTFOLIO
22.18.4 RECENT DEVELOPMENT
22.19 RECORDATI S.P.A.
22.19.1 COMPANY SNAPSHOT
22.19.2 REVENUE ANALYSIS
22.19.3 PRODUCT PORTFOLIO
22.19.4 RECENT DEVELOPMENT
22.2 SALIX PHARMACEUTICALS (A SUBSIDIARY OF BAUSCH HEALTH COMPANIES INC.)
22.20.1 COMPANY SNAPSHOT
22.20.2 REVENUE ANALYSIS
22.20.3 PRODUCT PORTFOLIO
22.20.4 RECENT DEVELOPMENTS
22.21 SUN PHARMACEUTICAL INDUSTRIES LTD.
22.21.1 COMPANY SNAPSHOT
22.21.2 REVENUE ANALYSIS
22.21.3 PRODUCT PORTFOLIO
22.21.4 RECENT DEVELOPMENT
22.22 TORRENT PHARMACEUTICALS LTD.
22.22.1 COMPANY SNAPSHOT
22.22.2 REVENUE ANALYSIS
22.22.3 PRODUCT PORTFOLIO
22.22.4 RECENT DEVELOPMENT
23 QUESTIONNAIRE
24 RELATED REPORTS
表のリスト
TABLE 1 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 3 MIDDLE EAST AND AFRICA OSMOTIC LAXATIVES IN LAXATIVES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA OSMOTIC LAXATIVES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA OSMOTIC LAXATIVES WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA OSMOTIC LAXATIVES WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA BULK LAXATIVES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA LUBRICANT AND EMOLLIENT LAXATIVES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA LUBRICANT AND EMOLLIENT LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA WITH FLAVOR IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA WITH FLAVOR IN LAXATIVE MARKET, BY FLAVOR, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA WITHOUT FLAVOR IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA SYNTHETIC IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA NATURAL IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA LAXATIVE MARKET, INDICATION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA CHRONIC CONSTIPATION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA OPIOID-INDUCED CONSTIPATION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA ACUTE CONSTIPATION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA OTHERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 30 MIDDLE EAST AND AFRICA OVER THE COUNTER IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA PRESCRIPTION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA TABLETS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA CAPSULES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA POWDER IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA LIQUID & GELS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA SUPPOSITORIES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA OTHERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA ORAL IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA RECTAL IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA ADULTS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA CHILDREN IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA HOSPITALS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA PHARMACY STORES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA ELDERLY CARE CENTERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA HOME HEALTHCARE IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA GROCERY/HEALTH AND BEAUTY STORES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA OTHERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA DIRECT SALES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA WHOLE SALERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA OTHERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 56 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 57 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 58 MIDDLE EAST & AFRICA LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 59 MIDDLE EAST & AFRICA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 62 MIDDLE EAST & AFRICA OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 63 MIDDLE EAST & AFRICA BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 64 MIDDLE EAST & AFRICA LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 65 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 66 MIDDLE EAST & AFRICA WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 67 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 68 MIDDLE EAST & AFRICA SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 69 MIDDLE EAST & AFRICA NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 70 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 71 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 72 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 73 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 74 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 75 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 76 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 78 SAUDI ARABIA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 79 SAUDI ARABIA LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 80 SAUDI ARABIA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 81 SAUDI ARABIA OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 SAUDI ARABIA OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 83 SAUDI ARABIA OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 84 SAUDI ARABIA BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 85 SAUDI ARABIA LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 86 SAUDI ARABIA LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 87 SAUDI ARABIA WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 88 SAUDI ARABIA LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 89 SAUDI ARABIA SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 90 SAUDI ARABIA NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 91 SAUDI ARABIA LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 92 SAUDI ARABIA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 93 SAUDI ARABIA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 94 SAUDI ARABIA LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 95 SAUDI ARABIA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 96 SAUDI ARABIA LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 97 SAUDI ARABIA LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 98 SAUDI ARABIA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 99 SOUTH AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 100 SOUTH AFRICA LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 101 SOUTH AFRICA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 102 SOUTH AFRICA OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 103 SOUTH AFRICA OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 104 SOUTH AFRICA OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 105 SOUTH AFRICA BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 106 SOUTH AFRICA LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 107 SOUTH AFRICA LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 108 SOUTH AFRICA WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 109 SOUTH AFRICA LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 110 SOUTH AFRICA SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 111 SOUTH AFRICA NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 112 SOUTH AFRICA LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 113 SOUTH AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 114 SOUTH AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 115 SOUTH AFRICA LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 116 SOUTH AFRICA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 117 SOUTH AFRICA LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 118 SOUTH AFRICA LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 119 SOUTH AFRICA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 120 U.A.E. LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 121 U.A.E. LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 122 U.A.E. STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 123 U.A.E. OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 124 U.A.E. OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 125 U.A.E. OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 126 U.A.E. BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 127 U.A.E. LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 U.A.E. LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 129 U.A.E. WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 130 U.A.E. LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 131 U.A.E. SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 132 U.A.E. NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 133 U.A.E. LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 134 U.A.E. LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 135 U.A.E. LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 136 U.A.E. LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 137 U.A.E. LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 138 U.A.E. LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 139 U.A.E. LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 140 U.A.E. LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 141 ISRAEL LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 142 ISRAEL LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 143 ISRAEL STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 144 ISRAEL OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 145 ISRAEL OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 146 ISRAEL OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 147 ISRAEL BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 148 ISRAEL LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 149 ISRAEL LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 150 ISRAEL WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 151 ISRAEL LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 152 ISRAEL SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 153 ISRAEL NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 154 ISRAEL LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 155 ISRAEL LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 156 ISRAEL LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 157 ISRAEL LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 158 ISRAEL LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 159 ISRAEL LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 160 ISRAEL LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 161 ISRAEL LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 162 KUWAIT LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 163 KUWAIT LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 164 KUWAIT STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 165 KUWAIT OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 166 KUWAIT OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 167 KUWAIT OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 168 KUWAIT BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 169 KUWAIT LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 170 KUWAIT LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 171 KUWAIT WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 172 KUWAIT LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 173 KUWAIT SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 174 KUWAIT NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 175 KUWAIT LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 176 KUWAIT LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 177 KUWAIT LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 178 KUWAIT LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 179 KUWAIT LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 180 KUWAIT LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 181 KUWAIT LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 182 KUWAIT LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 183 EGYPT LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 184 EGYPT LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 185 EGYPT STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 186 EGYPT OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 187 EGYPT OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 188 EGYPT OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 189 EGYPT BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 190 EGYPT LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 191 EGYPT LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 192 EGYPT WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 193 EGYPT LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 194 EGYPT SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 195 EGYPT NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 196 EGYPT LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 197 EGYPT LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 198 EGYPT LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 199 EGYPT LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 200 EGYPT LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 201 EGYPT LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 202 EGYPT LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 203 EGYPT LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 204 REST OF MIDDLE EAST & AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 205 REST OF MIDDLE EAST & AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (UNITS)
図表一覧
FIGURE 1 MIDDLE EAST AND AFRICA LAXATIVE MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA LAXATIVE MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA LAXATIVE MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA LAXATIVE MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA LAXATIVE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA LAXATIVE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA LAXATIVE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA LAXATIVE MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST AND AFRICA LAXATIVE MARKET: MARKET INDICATION COVERAGE GRID
FIGURE 10 MIDDLE EAST AND AFRICA LAXATIVE MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF CONSTIPATION, GERIATRIC POPULACE AND INCREASED USE OF OTC LAXATIVE IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA LAXATIVE MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 OSMOTIC LAXATIVES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA LAXATIVE MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA LAXATIVE MARKET
FIGURE 14 PREVALENCE OF CONSTIPATION IN THE AMERICAS, EUROPE AND INDIA
FIGURE 15 PREVALENCE DATA INFOGRAPHICS IN ELDERLY MALES AND FEMALES REPORTED IN THE FOLLOWING COUNTRIES
FIGURE 16 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY TYPE, 2020
FIGURE 17 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 18 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 19 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY FLAVORS, 2020
FIGURE 21 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY FLAVORS, 2019-2028 (USD MILLION)
FIGURE 22 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY FLAVORS, CAGR (2021-2028)
FIGURE 23 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY FLAVORS, LIFELINE CURVE
FIGURE 24 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SOURCE, 2020
FIGURE 25 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SOURCE, 2019-2028 (USD MILLION)
FIGURE 26 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SOURCE, CAGR (2021-2028)
FIGURE 27 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY INDICATION, 2020
FIGURE 29 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY INDICATION, 2019-2028 (USD MILLION)
FIGURE 30 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY INDICATION, CAGR (2021-2028)
FIGURE 31 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 32 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY MODE OF PURCHASE, 2020
FIGURE 33 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
FIGURE 34 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY MODE OF PURCHASE, CAGR (2021-2028)
FIGURE 35 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 36 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DOSAGE FORM, 2020
FIGURE 37 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DOSAGE FORM, 2019-2028 (USD MILLION)
FIGURE 38 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DOSAGE FORM, CAGR (2021-2028)
FIGURE 39 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DOSAGE FORM, LIFELINE CURVE
FIGURE 40 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY ROUTE OF ADMINISTRATION, 2020
FIGURE 41 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
FIGURE 42 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2021-2028)
FIGURE 43 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 44 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY POPULATION TYPE, 2020
FIGURE 45 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY POPULATION TYPE, 2019-2028 (USD MILLION)
FIGURE 46 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY POPULATION TYPE, CAGR (2021-2028)
FIGURE 47 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY POPULATION TYPE, LIFELINE CURVE
FIGURE 48 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SALES CHANNEL, 2020
FIGURE 49 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SALES CHANNEL, 2019-2028 (USD MILLION)
FIGURE 50 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SALES CHANNEL, CAGR (2021-2028)
FIGURE 51 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SALES CHANNEL, LIFELINE CURVE
FIGURE 52 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 53 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 54 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 55 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 56 MIDDLE EAST & AFRICA LAXATIVE MARKET: SNAPSHOT (2020)
FIGURE 57 MIDDLE EAST & AFRICA LAXATIVE MARKET: BY COUNTRY (2020)
FIGURE 58 MIDDLE EAST & AFRICA LAXATIVE MARKET: BY COUNTRY (2021 & 2028)
FIGURE 59 MIDDLE EAST & AFRICA LAXATIVE MARKET: BY COUNTRY (2020 & 2028)
FIGURE 60 MIDDLE EAST & AFRICA LAXATIVE MARKET: BY TYPE (2021-2028)
FIGURE 61 MIDDLE EAST AND AFRICA LAXATIVE MARKET: COMPANY SHARE 2020 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
